Kolexia
Denis Celine
Médecine générale
Cabinet libéral
Paris, France
64 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Maladies de von Willebrand Hémorragie Maladie de von Willebrand de type 2 Hémophilie A Troubles liés à une substance Thrombopénie Maladie chronique Purpura Maladie de von Willebrand de type 3

Industries

{{person.topindus1.name}}
{{person.topindus1.tot}} collaboration(s)
Dernière en {{person.topindus1.last}}
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Développement d’un nouvel outil d’imagerie ciblant un nouveau biomarqueur en oncologie : le récepteur à la vasopressine de type 2 (V2R)
9e Journées Francophones de Médecine nucléaire - Paris   01 mars 2023
Domain-specific nanobodies distinguish intact and proteolyzed forms of von Willebrand factor in congenital von Willebrand disease
Abstracts of the ISTH 2022 Congress of the International Society of Thrombosis and Haemostasis, July 9–13, 2022   21 octobre 2022
Effects of platelet-inspired haemostatic nanoparticles on bleeding in von Willebrand disease murine models
Abstracts of the ISTH 2022 Congress of the International Society of Thrombosis and Haemostasis, July 9–13, 2022   21 octobre 2022
Unique humanized mouse models of von Willebrand disease to implement the need for innovative therapeutic strategies
Abstracts of the ISTH 2022 Congress of the International Society of Thrombosis and Haemostasis, July 9–13, 2022   21 octobre 2022
Differences in bleeding profiles and venous clot structures between emicizumab and factor VIII-treated mice
Abstracts of the ISTH 2022 Congress of the International Society of Thrombosis and Haemostasis, July 9–13, 2022   21 octobre 2022
Emicizumab ameliorates hemostasis in von Willebrand Disease type 3 but not type 2A murine models
Abstracts of the ISTH 2022 Congress of the International Society of Thrombosis and Haemostasis, July 9–13, 2022   21 octobre 2022
Rôle du récepteur adipocytaire des glucocorticoïdes dans l’expansion et la vascularisation du tissu adipeux
Nutrition Clinique et Métabolisme   01 février 2022
44 Transplacental Delivery of Maternal FVIII for Induction of FVIII-Specific Immune Tolerance
Special Issue: Abstracts of the ISTH 2021 Virtual Congress of the International Society of Thrombosis and Haemostasis, July 17–21, 2021   07 octobre 2021
98 Antithrombotic Potential of a Single-domain Antibody Enhancing the Anticoagulant Activity of Protein S
Special Issue: Abstracts of the ISTH 2021 Virtual Congress of the International Society of Thrombosis and Haemostasis, July 17–21, 2021   07 octobre 2021
Resistance to Fibrinolysis in Critically Ill Patients with COVID-19 Can Be Overcome by N-acetylcysteine in vitro
Special Issue: Abstracts of the ISTH 2021 Virtual Congress of the International Society of Thrombosis and Haemostasis, July 17–21, 2021   07 octobre 2021